Compositions for nucleic acid delivery
The present invention is based, in part, upon the discovery of charged lipids that provide advantages when used in lipid particles for the in vivo delivery of a therapeutic agent. As such, described herein are compounds useful for delivering a nucleic acid to a cell.
1. A compound represented by formula XXXIII:
wherein,
R 1 and R 2 are each independently for each occurrence optionally substituted C 10 -C 30 alkyl, optionally substituted C 10 -C 30 alkoxy, optionally substituted C 10 -C 30 alkenyl, optionally substituted C 10 -C 30 alkenyloxy, optionally substituted C 10 -C 30 alkynyl, optionally substituted C 10 -C 30 alkynyloxy, or optionally substituted C 10 -C 30 acyl;
E is OC(O)N(R′);
R 3 has the formula:
wherein
each of Y 1 , Y 2 , Y 3 , and Y 4 , independently, is alkyl, cycloalkyl, aryl, aralkyl, or alkynyl; or
any two of Y 1 , Y 2 , and Y 3 are taken together with the N atom to which they are attached to form a 3- to 8-member heterocycle; or
Y 1 , Y 2 , and Y 3 are all taken together with the N atom to which they are attached to form a bicyclic 5- to 12-member heterocycle;
each R n , independently, is H, halo, cyano, hydroxy, amino, alkyl, alkoxy, cycloalkyl, aryl, heteroaryl, or heterocyclyl;
L 3 is a bond, —N(Q)-, —O—, —S—, —(CR 5 R 6 ) a —, —C(O)—, or a combination of any two of these;
L 4 is a bond, —N(Q)-, —O—, —S—, —(CR 5 R 6 ) a —, —C(O)—, or a combination of any two of these;
L 5 is a bond, —N(Q)-, —O—, —(CR 5 R 6 ) a —, —C(O)—, or a combination of any two of these;
each occurrence of R 5 and R 6 is, independently, H, halo, cyano, hydroxy, amino, alkyl, alkoxy, cycloalkyl, aryl, heteroaryl, or heterocyclyl: or two R 5 groups on adjacent carbon atoms are taken together to form a double bond between their respective carbon atoms: or two R 5 groups on adjacent carbon atoms and two R 6 groups on the same adjacent carbon atoms are taken together to form a triple bond between their respective carbon atoms;
each a, independently, is 0, 1, 2, or 3;
R′ is H, alkyl, heteroalkyl, aralkyl, cyclic alkyl, or heterocyclyl;
wherein
an R 5 or R 6 substituent from any of L 3 , L 4 , or L 5 is optionally taken with an R 5 or R 6 substituent from any of L 3 , L 4 , or L 5 to form a 3- to 8-member cycloalkyl, heterocyclyl, aryl, or heteroaryl group; and
any one of Y 1 , Y 2 , or Y 3 , is optionally taken together with an R 5 or R 6 group from any of L 3 , L 4 , and L 5 , and atoms to which they are attached, to form a 3- to 8-member heterocyclyl group; and
each Q, independently, is H, alkyl, acyl, cycloalkyl, alkenyl, alkynyl, aryl, heteroaryl or heterocyclyl.
2. The compound:
3. The compound of claim 1 , wherein R 3 has the formula:
4. The compound of claim 1 , wherein R 3 has the formula:
5. The compound of claim 1 , wherein R 3 has the formula: